Question 1

Am I eligible for this trial based on my current pain management?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients clinical trial (NCT00105287). Contact the study team or your healthcare provider for specific answers.

Question 2

How does OraVescent fentanyl compare to my current pain medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients clinical trial (NCT00105287). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of OraVescent fentanyl?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients clinical trial (NCT00105287). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients clinical trial (NCT00105287). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients clinical trial (NCT00105287). Contact the study team or your healthcare provider for specific answers.

Question 6

How long will the treatment last, and what does the process involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients clinical trial (NCT00105287). Contact the study team or your healthcare provider for specific answers.

What this study is about